How to Use Targeted Proteomics for Accurate Detection of Low-Abundance Proteins
In complex biological samples, protein abundances can span a dynamic range exceeding six orders of magnitude (10⁶). Many proteins with critical biological functions—such as hormone receptors, transcription factors, signaling molecules, and early-stage disease biomarkers—fall into the category of low-abundance proteins. Despite their vital roles in various biological processes, their detection is often hindered by low expression levels and complex sample backgrounds, making conventional discovery-based proteomic strategies, such as data-dependent acquisition (DDA), insufficiently sensitive. Targeted proteomics, through the use of predefined targets and highly selective scan strategies, provides a powerful solution for the accurate detection of low-abundance proteins.
Overcoming the Dynamic Range Bottleneck through Targeted Proteomics
1. Quantitative Advantages of MRM and PRM
Targeted proteomics leverages preselected peptides and specific ion transitions to selectively capture analyte signals, enabling repeated signal accumulation that enhances both signal-to-noise ratio and overall detection sensitivity.
(1) Multiple Reaction Monitoring (MRM), performed on triple quadrupole instruments, delivers high sensitivity with minimal background interference. This makes it particularly suitable for complex biological matrices such as serum and urine.
(2) Parallel Reaction Monitoring (PRM), commonly implemented on Orbitrap-based platforms, provides superior specificity compared to MRM. It enables discrimination of isobaric peptides and enhances quantitative accuracy, especially in multiplexed or complex assays.
Key Technical Strategies for Accurate Detection of Low-Abundance Proteins
1. Sample Preparation and Enrichment: Establishing a Robust Analytical Foundation
(1) Immuno-enrichment (SISCAPA): Specific peptides are enriched using antibodies to increase the signal-to-noise ratio.
(2) Desalting and high-pH reversed-phase fractionation: This step reduces sample complexity and prevents signal suppression caused by highly abundant proteins.
MtoZ Biolabs provides tailored immunoaffinity chromatography and high-selectivity digestion workflows based on the characteristics of target proteins, ensuring precise integration between upstream sample processing and downstream mass spectrometry analysis.
2. Optimization of Peptide Selection and Method Development
Target peptides are selected based on the absence of post-translational modifications, high ionization efficiency, and minimal isobaric interference. Instrumental parameters, including collision energy, retention time windows, and ion transitions, are carefully optimized to achieve maximal sensitivity and specificity for each peptide.
From Relative to Absolute: Achieving High-Accuracy Quantification Using Internal Standards
In addition to relative quantification, targeted proteomics enables absolute quantification through stable isotope-labeled standard (SIS) peptides. This approach yields precise concentration data for individual proteins and is widely used in translational and clinical biomarker research.
MtoZ Biolabs supports the development of SIS-based targeted quantification methods applicable to various biomarker studies, including oncology, metabolic diseases, and immunological disorders.
Accurate detection of low-abundance proteins remains both a technical challenge and a critical driver of precision medicine. With high selectivity, reproducibility, and translational value, targeted proteomics plays an essential role in biomarker discovery, therapeutic evaluation, and clinical applications. At MtoZ Biolabs, we focus on capturing the subtle yet significant protein signals within complex biological matrices. Through advanced platforms and refined protocols, we empower researchers to comprehensively map the proteome’s most elusive components.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
